Chan Ho Lim retweeted
Been working my whole life for this moment; officially applied to General Surgery residency! #Match2027
From graduating from @AUBMC_Official to my current postdoctoral research fellowship @Tulane, I’m excited to take the next step toward becoming a surgeon-scientist. Incredibly grateful to everyone who has supported and guided me along the way.
Looking forward to connecting with colleagues and programs throughout the interview season! #MedTwitter #GeneralSurgery
AAMC ID: 14997886
Chan Ho Lim retweeted
AF recurs in up to 50% post-ablation, what's next is often just operator preference. Our study in Europace of 3,100+ patients: redo ablation cut death/stroke/HF by 35% vs. cardioversion (NNT=14). 🫀⚡
@nmarrouche @HanFengGHD @QMarashly
📄 doi.org/10.1093/europace/eua…
#AFib #EPeeps
Chan Ho Lim retweeted
Excited to share that the HEARTBEAT study design is out! Let’s see where PPG assessment in a real-world setting can lead us to in Cardiovascular medicine!
@nmarrouche @MassadChristian @HanFengGHD @chanholim @AlaAssaf3 @BsoulMayana @TulaneTriad @QMarashly
academic.oup.com/ehjdh/advan…
Chan Ho Lim retweeted
Replying to @BidaouiGhassan @nmarrouche @MassadChristian @chanholim @AlaAssaf3 @BsoulMayana @TulaneTriad @QMarashly
A major step toward understanding what continuous, real-world wearable monitoring can tell us beyond the clinic. Proud of the team behind #HEARTBEAT — and even more excited for the clinical outcome findings coming next. Stay tuned! #DigitalHealth #CardvascularDisease #Wearables
Chan Ho Lim retweeted
Excited to share new work in @JACCJournals #Advances by ⭐️ @TulaneMedicine #grad & soon to be July1 #IM #residents Drs. Cecile McGarvey & Emma Lunn with great guidance from @HanFengGHD @nmarrouche. Read more about #OAC differences for #Afib in #females. 👇jacc.org/doi/10.1016/j.jacad…
Chan Ho Lim retweeted
Excellent work from @MassadChristian and the team!
Extra-PV ablation using the VARIPULSE catheter appears to be safe and effective, with high success rates and a favorable complication profile during medium- to long-term follow-up.
Exciting progress in AF ablation strategies.
Chan Ho Lim retweeted
Huge congratulations to @YingshuoL, our AI leader at TRIAD, for presenting the team’s work and vision for AI in cardiology at Grand Rounds at Tulane School of Medicine! Exciting to see how AI is transforming both research and clinical care in arrhythmia at Tulane.
Chan Ho Lim retweeted
Congrats to @mabou_khalil Great work from HEARTBEAT study, a prospective smartwatch cohort in Louisiana with high cardiovascular risk. Lower income was associated with greater comorbidity burden and higher risk of death, stroke, or hospitalizations. More to come. #ACC26
Chan Ho Lim retweeted
⭐️@TulaneTriad Yingshou Liu sharing his innovative work on #AI using #PPG for risk prediction of #Afib. Amazing work and more to come from #Heartbeat study! The future is exciting. @nmarrouche @TulaneMedicine @TulaneDDoM @MassadChristian @SamsungHealth @chanholim @HanFengGHD
Chan Ho Lim retweeted
Congrats to Dr.@BsoulMayana on her impactful work 👏 AF patients treated with amiodarone show higher mortality risk, consistent across CHA₂DS₂-VASc strata (≥2 and <2). Important signal that risk persists regardless of baseline stroke risk.
#ACC26 @TulaneDDoM @TulaneTriad
Chan Ho Lim retweeted
Great session on AI in cardiology. Thank you @lamcardio and Dr. Seinath Adusumalli for putting it together!
Incredible insights from @rohan_khera and @zachia5 on translating AI into clinical practice and trials at Yale and Mayo Clinic. Excited about the future medicine. #ACC26
Chan Ho Lim retweeted
Big Saturday at ACC 2026 Scientific Session 🚀
Tulane Cardiology & TRIAD across AF, ablation, health equity, prevention, CVD, PAD & HF. A full day of science.
Proud of the team and excited. @JoseWileyforNYC @AIrimpen
@AmitabhCPandey @nmarrouche #ACC26 See schedule 👇
Chan Ho Lim retweeted
My most favorite session at #WesternAFib. Since I first attended, @netta_doc always follows every session and gives the final wrap-up with highlights of the whole symposium. Refreshes all the remaining controversial topics and makes me think deeper every time. Really grateful 🙏
Chan Ho Lim retweeted
Congratulations to @montaser4k and @QMarashly on this outstanding work. 🎉
Concomitant PFA + LAAO may represent a safer, streamlined strategy for AF patients:
• Lower leak
• Shorter procedure
• Comparable complications/recurrence
Read more: onlinelibrary.wiley.com/doi/…
#AF #PFA
The Top AI Papers of the Week (February 16-22)
- GLM-5
- SkillsBench
- MemoryArena
- Team of Thoughts
- AI Delegation Framework
- Lossless Context Management
Read on for more:
Chan Ho Lim retweeted
AF+HFpEF are vicious twins, feeding symptom burden, worsening outcomes, and often under-detected. Can systematic screening and targeted care finally break the cycle?
📍 Western AFib Symposium
🗓️ Fri,Feb 27, 2026, 10:50 am
Join the buzz around the CASTLE-HFpEF trial
#WAFIB2026 #EP
Introducing ChatGPT Health — a dedicated space for health conversations in ChatGPT. You can securely connect medical records and wellness apps so responses are grounded in your own health information.
Designed to help you navigate medical care, not replace it.
Join the waitlist to get early access.
openai.com/index/introducing…
Chan Ho Lim retweeted
Proud to share our new publication in @JACCJournals EP
Grateful for the mentorship of @nmarrouche , @chanholim , @HanFengGHD . Thanks @DrJasonAndrade for the great input in the editorial
Does SMURDEN correlate with Qol and Symptoms after ablation ?
jacc.org/doi/10.1016/j.jacep…
Chan Ho Lim retweeted
Stronger Normalization-Free Transformers – new paper.
We introduce Derf (Dynamic erf), a simple point-wise layer that lets norm-free Transformers not only work, but actually outperform their normalized counterparts.
Chan Ho Lim retweeted
Important work by @MekhaelMario detailing the use of #AI to further analyze data from clinical trials! #AI algorithm studying #DECAAFII found that targeting atrial myopathy/fibrosis in younger #afib population led to significant reduction in burden! @omwazni @PrashSanders @AmitabhCPandey @chris_sohns @Phiso_de @NazemAkoum @Drdevignair @S_NarayanMD @DrRoderickTung @TinaBaykaner
Application of Artificial Intelligence to Analyze Data from Randomized Controlled Trials: An Example from DECAAF-II #OpenAccess
@MekhaelMario
heartrhythmjournal.com/artic…





























